These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23630050)

  • 21. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Jan; 53(1):jrm00133. PubMed ID: 33206198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm.
    Ashford S; Slade M; Turner-Stokes L
    Disabil Rehabil; 2013 Aug; 35(18):1513-8. PubMed ID: 23294435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM; Bayle N; Goldberg S; Simpson DM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin should be first-line treatment for poststroke spasticity.
    Sheean G
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):359. PubMed ID: 19289475
    [No Abstract]   [Full Text] [Related]  

  • 27. [The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury].
    Akulov MA; Hat'kova SE; Mokienko OA; Orlova OR; Usachev DY; Zakharov VO; Orlova AS; Tomskiy AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):30-35. PubMed ID: 27635608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
    McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
    J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
    Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
    BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study.
    Picelli A; Vallies G; Chemello E; Gavras A; Castellazzi P; Meschieri A; Serina A; Gandolfi M; Baricich A; Santamato A; Cisari C; Smania N
    J Rehabil Med; 2017 May; 49(5):410-415. PubMed ID: 28471469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
    Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL; Kong KH; Goh KJ; Kumthornthip W; Mok VC; Delgado-De Los Santos MM; Chua KS; Abdullah SJ; Zakine B; Maisonobe P; Magis A; Wong KS
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: grasp strategies and kinematics of reach-to-grasp movements.
    Bensmail D; Robertson J; Fermanian C; Roby-Brami A
    Neurorehabil Neural Repair; 2010 Feb; 24(2):141-51. PubMed ID: 19786722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment goals in patients with post-stroke upper limb spasticity following injection of botulinum toxin A : Results of the German-Austrian subgroup of the ULIS-II study].
    Fheodoroff K; Dressler D; Woldag H; Koßmehl P; Koch M; Maisonobe P; Reichel G
    Nervenarzt; 2019 Apr; 90(4):361-370. PubMed ID: 30324541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.